TMEM136 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.786400E-01
Normal-vs-Stage2
8.155800E-01
Normal-vs-Stage3
5.489200E-01
Normal-vs-Stage4
9.635200E-01
Stage1-vs-Stage2
4.443400E-01
Stage1-vs-Stage3
9.890800E-01
Stage1-vs-Stage4
3.261000E-01
Stage2-vs-Stage3
5.425800E-01
Stage2-vs-Stage4
7.428200E-01
Stage3-vs-Stage4
4.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.929000E-01
Normal-vs-AfricanAmerican
5.712600E-01
Normal-vs-Asian
8.683000E-01
Caucasian-vs-AfricanAmerican
6.285500E-02
Caucasian-vs-Asian
7.737200E-01
AfricanAmerican-vs-Asian
3.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.721800E-01
Normal-vs-Female
7.461600E-01
Male-vs-Female
8.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.047000E-01
Normal-vs-Age(41-60Yrs)
9.449800E-01
Normal-vs-Age(61-80Yrs)
6.319600E-01
Normal-vs-Age(81-100Yrs)
4.940200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.059400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.729000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.176600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.462000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.440840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.408000E-01
Normal-vs-Daily Drinker
8.063000E-01
Normal-vs-Weekly Drinker
9.589200E-01
Normal-vs-Occasional Drinker
7.349000E-01
Normal-vs-Social Drinker
5.627800E-01
Non Drinker-vs-Daily Drinker
9.842400E-01
Non Drinker-vs-Weekly Drinker
6.348600E-01
Non Drinker-vs-Occasional Drinker
8.288200E-01
Non Drinker-vs-Social Drinker
5.601000E-01
Daily Drinker-vs-Weekly Drinker
5.959400E-01
Daily Drinker-vs-Occasional Drinker
8.343600E-01
Daily Drinker-vs-Social Drinker
5.407600E-01
Weekly Drinker-vs-Occasional Drinker
4.970200E-01
Weekly Drinker-vs-Social Drinker
3.002600E-01
Occasional Drinker-vs-Social Drinker
7.022800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.899700E-02
Normal-vs-Grade 2
1.287890E-02
Normal-vs-Grade 3
7.979200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.556220E-01
Grade 1-vs-Grade 3
2.206400E-01
Grade 1-vs-Grade 4
5.899700E-02
Grade 2-vs-Grade 3
8.830200E-01
Grade 2-vs-Grade 4
1.287890E-02
Grade 3-vs-Grade 4
7.979200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.512400E-01
Normal-vs-NonDiabetic
8.099200E-01
Diabetic-vs-NonDiabetic
8.333800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.876600E-01
Normal-vs-NoPancreatitis
7.013600E-01
Pancreatitis-vs-NoPancreatitis
4.988500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.296800E-01
Normal-vs-N1
6.817600E-01
N0-vs-N1
3.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.588800E-01
Normal-vs-TP53-NonMutant
3.408400E-01
TP53-Mutant-vs-TP53-NonMutant
7.770700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
